{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/coeliac-disease/background-information/prognosis/","result":{"pageContext":{"chapter":{"id":"9db3868a-f808-5034-8563-58a2c84ab545","slug":"prognosis","fullItemName":"Prognosis","depth":2,"htmlHeader":"<!-- begin field 8a20cb67-0696-462f-b382-4bdd07203d65 --><h2>What is the prognosis?</h2><!-- end field 8a20cb67-0696-462f-b382-4bdd07203d65 -->","summary":"","htmlStringContent":"<!-- begin item 2e9b5c91-5ba2-4ae6-a3d0-5424be51e69d --><!-- begin field b3b9f595-3ad0-4d1e-987c-d80e2b6d6109 --><p><strong>The majority of people with confirmed coeliac disease report a rapid improvement in symptoms after starting a gluten-free diet, and have a normal life expectancy </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015a</a>]<strong>.</strong></p><ul><li>The resolution of symptoms of coeliac disease does not necessarily correlate with the degree of duodenal mucosal recovery.<ul><li>A European Society for the Study of Coeliac Disease guideline cites studies showing that in people adhering to a strict gluten-free diet for more than 1 year, up to 75% had remission of symptoms and biopsies showed normal villous architecture, but 50–70% still had signs of mucosal damage (increased intraepithelial lymphocytes) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].</li></ul></li><li>'Slow responders' describes the 7–30% of adults with coeliac disease who continue to have persistent symptoms, signs, or laboratory abnormalities of coeliac disease despite a gluten-free diet for at least 6–12 months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].<ul><li>Expert opinion in a review article defines 'slow responders' as people with progressive improvement in symptoms and mucosal damage, but full remission does not occur for at least 1–2 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].</li></ul></li><li>'Non-responsive coeliac disease' refers to people with persistent symptoms and enteropathy that do not respond after 6–12 months on a self-reported gluten-free diet, and is most commonly due to inadvertent gluten ingestion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Cichewicz, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>].<ul><li>The British Society of Gastroenterology guidelines suggest that 4–30% of people with coeliac disease report persisting symptoms and are considered to be non-responsive [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>].</li></ul></li><li>'Refractory coeliac disease' refers to people with persistent or recurrence of otherwise unexplained malabsorption symptoms and villous atrophy on duodenal biopsy, despite strict adherence to a gluten-free diet for at least 12 months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].<ul><li>About 10% of people with non-responsive coeliac disease may have refractory disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>].</li><li>It is mostly diagnosed after the age of 50 years, and incidence rates range from 0.04 to 1.5% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].</li><li>There are two subtypes, and the high mortality associated with type II disease is due to nutritional complications and the higher risk of transformation into enteropathy-associated T-cell lymphoma (EATL), which occurs in 33–52% of cases within 5 years after diagnosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].</li></ul></li><li>People with coeliac disease display possible excess mortality compared with the general population, but the evidence in the literature is conflicting, and there is no consensus of opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>]. A UK primary care cohort study of cause-specific mortality for people with coeliac disease (n = 10,825) found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Abdul Sultan, 2015</a>]:<ul><li>The overall mortality rate among people with coeliac disease was 128 per 10,000 person-years, compared with 153 per 10,000 in controls (hazard ratio 0.94).</li><li>People with coeliac disease had 0.15% excess risk of deaths from non-Hodgkin’s lymphoma from the general population baseline risk, up to 10 years post-diagnosis.</li><li>People with coeliac disease had no major excess risk of cancer, gastrointestinal or respiratory disease-related or cardiovascular-related mortality compared with the general population, up to 10 years post-diagnosis.</li></ul></li></ul><!-- end field b3b9f595-3ad0-4d1e-987c-d80e2b6d6109 --><!-- end item 2e9b5c91-5ba2-4ae6-a3d0-5424be51e69d -->","topic":{"id":"1c1a5a3f-9b4d-5aca-b1c7-548672455692","topicId":"b0551c5c-9ab6-4db2-b8e5-27b98c6108ac","topicName":"Coeliac disease","slug":"coeliac-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"1ab49395-0a38-5106-ac8c-081d06df8957","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"42fe31c7-8b64-527e-bd5e-51c32714ee29","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"26b08904-13dc-5b32-8bc4-2549fa573fb3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5c0dee49-ba90-52f3-a99a-676cb4ca5418","slug":"changes","fullItemName":"Changes"},{"id":"875d3bb9-e2eb-51af-b90b-a59a08a4c149","slug":"update","fullItemName":"Update"}]},{"id":"9ced2297-bd68-58b0-b12e-d660074f8e9e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"394005c9-726f-5f88-be40-717a7d0adb86","slug":"goals","fullItemName":"Goals"},{"id":"2f234477-2111-51de-8800-18b0231b7b5c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"82c4f886-1b62-5a2f-b956-e939a3736a77","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"352349eb-c34b-5c8a-8f35-cc52c1e427e0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ba3abfa3-9c4f-527d-bc4a-30d501245cb7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67796a49-6946-5a26-9be6-3d4e8ae58914","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d877907c-0181-5747-953a-1057a01509ee","slug":"definition","fullItemName":"Definition"},{"id":"13d4bc73-968e-5163-b7b1-3a66b2f0e52c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f33b46df-e16f-5d24-a608-1b5b4a4b605a","slug":"causes","fullItemName":"Causes"},{"id":"09a61360-9601-5caa-84af-2136bd4a7603","slug":"complications","fullItemName":"Complications"},{"id":"9db3868a-f808-5034-8563-58a2c84ab545","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"13e9616c-5ad7-54a8-af68-dad57366685f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"77ada14b-2c51-5bf2-894b-526f099ef23e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d056d742-1aa4-57bc-8e9b-3730a715a6dd","slug":"assessment","fullItemName":"Assessment"},{"id":"98e1c8e5-e970-57a5-a01e-0d4ad52bc8ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4561ec77-0c01-5346-8f45-78e225038140","fullItemName":"Management","slug":"management","subChapters":[{"id":"ee522102-0563-555f-a5b5-a9199c67b6a8","slug":"management-of-confirmed-coeliac-disease","fullItemName":"Scenario: Management of confirmed coeliac disease"}]},{"id":"e9edb239-af7b-54d7-ad64-dadf49939e27","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc5fb8ef-a4c4-581b-8828-fa524bfc69ca","slug":"gluten-free-products","fullItemName":"Gluten-free products"}]},{"id":"76c25337-4d0a-5036-b7cf-1c7ca39a7e48","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6001d4b8-f58d-5d70-a396-3f47044d6a24","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"cf74b6f9-a29b-5108-b99b-0d2d5782850a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"472110e6-ab58-582f-8614-7d056d174365","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4c098beb-df9b-5e8d-8fdf-0197b1dd54d3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9a97c354-b836-5bab-8cbf-eb9d5698f9cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a79c40d9-503b-5914-bb11-f0370fa4119a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"aa655679-10e1-5946-87a1-3dfdf6ad91f3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}